riods (SOREMPs) during five naps. The diagnosis of narcolepsy type 2 was made, 4 for which he was receiving modafinil 200 mg. After being prescribed the medicine, hypersomnia was significantly improved and he had a relatively good quality of life with stable daily activities.
On examination, he had a swollen left lower leg, and there was no other significant finding on systemic examination, including genital ulcer, skin lesion and eye inflammation. Peripheral arterial pulses were normal. Radiographs of both legs were normal. Ultrasonography revealed acute SVT in the left small saphenous vein (Fig. 1) . Laboratory investigations revealed normal total and differential cell counts. Antinuclear factor, antiphospholipid antibodies, lupus anticoagulant and Venereal Disease Research Lavaratory titers were negative. His coagulation profile was normal except for the isolated abnormality of PS deficiency; total PS activity level was 41% and functional PS activity level was 30%. Therefore, we made the diagnosis of SVT associated with PS deficiency in this patient with narcolepsy. This patient was managed with thrombectomy and supportive management including non-steroidal anti-inflammatory drugs and compression stockings.
DISCUSSION
We reported PS deficiency in an adolescent with narcolepsy type 2. He was diagnosed with narcolepsy type 2 at the age of 16 years, according to the International Classification of Sleep Disorders-3 (mean sleep latency 2.5 min; SOREMPs 4), 4 and his coagulation profile showed an isolated abnormality of PS deficiency. SVT was confirmed by Doppler ultrasonography. We found no evidence of other acquired or inherited thrombophilia. We excluded Behcet disease, neoplasia, and Buerger disease through medical history and follow-up. In our patient with narcolepsy, PS deficiency as well as long-distance travel on long-haul flights may have contributed to SVT.
Congenital PS deficiency was first reported in 1984 5 and has subsequently been described in numerous families. 6 Acquired deficiency of PS is observed in several pathological states which may be associated with an increased thrombotic risk. 1 Autoimmune PS deficiency can develop following an infection, leading to devastating thrombotic manifestations, especially in children. 3 PS deficiency in this patient is more likely to be acquired than inherited, because there was no family history of coagulopathy. Additionally other acquired causes including liver disease, DIC etc., were excluded through medical history and laboratory investigations. Therefore, we speculated that autoimmune mechanism may have contributed to PS deficiency in our patient.
A particularly interesting finding was that he had narcolepsy. Narcolepsy is characterized by hypersomnia, cataplexy etc. 7 Although the disease was first described towards the end of the 19th century, the underlying pathomechanisms were described only within the last decade. 8 The exact mechanisms of autoimmunity are poorly understood, but an increase in the incidence of narcolepsy after H1N1 infection and vaccination supported the hypothesis of an immune-mediated pathogenesis of narcolepsy. The generation of an experimental animal model of autoimmune narcolepsy could suggest the mechanism of autoimmune attack against hypocretin-producing cells. 8 Individuals affected by narcolepsy present with not only sleep problems, but they also have substantially higher rates of medical (hypercholesterolemia, diseases of the digestive system, heart diseases etc.) and psychiatric diseases (e.g., major depressive disorder, bipolar disorder etc.) than the general population. 9 Comorbidities are represented by endocrine, neurological and musculoskeletal disorders. 10 These results clearly illustrate the complexity of medical history and vulnerability of individuals with narcolepsy. Although there is no previous report of narcolepsy associated with PS deficiency and the relationship between these two diseases has not yet been investigated, there is an ongoing study which is recruiting the patient groups that have coagulopathy and narcolepsy (http://www.ehealthme.com/cs/ thrombosis/narcolepsy/). Therefore, we suggest that these two diseases may be interrelated with each other in view of autoimmunity, and PS deficiency can be one of the medical conditions associated with narcolepsy.
We could make the diagnosis of SVT associated with PS deficiency in this adolescent with narcolepsy. It cannot be ruled out that PS deficiency may be only comorbidity in our narcolepsy patient because the relationship between these two diseases has not yet been investigated. However, both diseases have a similar pathomechanism in view of autoimmunity. Our case suggested that the development of PS deficiency and narcolepsy can be interrelated with each other. Additionally, we indicated that further study exploring the relationship between narcolepsy and PS deficiency is needed. This case report can serve as the starting point for further studies to evaluate the relationship be- Fig. 1 . Ultrasonography of the left ankle shows intraluminal acute thrombosis in the small saphenous vein (white arrow).
